Evidence for circulatory benefits of resveratrol in humans

Annals of the New York Academy of Sciences

Volumn 1290, Issue 1, 2013, Pages 52-58

  Wong, Rachel H X ^a   Coates, Alison M ^a   Buckley, Jonathan D ^a   Howe, Peter R C ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Endothelial function; Flow mediated dilation; Human; Resveratrol; trans resveratrol; Vasodilator responsiveness

Indexed keywords

COLECALCIFEROL; NITRIC OXIDE; PLACEBO; QUERCETIN; RESVERATROL;

ARTICLE; BIOAVAILABILITY; CAPILLARY ENDOTHELIUM; CARDIOVASCULAR RISK; COGNITION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; HUMAN; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X;

EID: 84950170996     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12155     Document Type: Article

References (40)

1. Ruitenberg, A., T. den Heijer, S.L.M. Bakker, et al. 2005. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann. Neurol. 57: 789-794.
2. Davison, K., A.M. Coates, J.D. Buckley & P.R. Howe. 2008. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. (Lond). 32: 1289-1296.
3. Hooper, L., K. Colin, A. Asmaa, et al. 2012. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 95: 740-751.
4. Scholey, A.B, S.J. French, P.J. Morris, et al. 2009. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J. Psychopharmacol. 24: 1505-1514.
5. Li, H., N. Xia & U. Förstermann. 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26: 102-110.
6. Félétou, M. 2011. The endothelium, part I: multiple functions of the endothelial cells-focus on endothelium-derived vasoactive mediators. D.N. Granger & J.P. Granger, Eds. San Rafael, CA: Morgan & Claypool Life Sciences.
7. Celermajer, D.S., K.E. Sorensen, C. Bull, et al. 1994. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects related to coronary risk-factors and their interaction. J. Am. Coll. Cardiol. 24: 1468-1474.
8. Zimmermann, C. & R.L. Haberl. 2003. L-arginine improves diminished cerebral CO2 reactivity in patients. Stroke 34: 643-647.
9. Markus, H. & M. Cullinane. 2001. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 124: 457-467.
10. Silvestrini, M., P. Pasqualetti, R. Baruffaldi, et al. 2006. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37: 1010-1015.
11. Thijssen, D.H.J., M.A. Black, K.E. Pyke, et al. 2011. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am. J. Physiol Heart Circ. Physiol. 300: H2-H12.
12. Yavuz, B.B., B. Yavuz, D.D. Sener, et al. 2008. Advanced age is associated with endothelial dysfunction in healthy elderly subjects. Gerontology 54: 153-156.
13. Palmieri, V., C. Russo, S. Pezzullo, et al. 2011. Relation of flow-mediated dilation to global arterial load: impact of hypertension and additional cardiovascular risk factors. Int. J. Cardiol. 152: 225-230.
14. Davison, K., S. Bircher, A. Hill, et al. 2010. Relationships between obesity, cardiorespiratory fitness, and cardiovascular function. J. Obes. 2010: Article ID 191253, 7 pp.
15. Henry, R.M.A., I. Ferreira, P.J. Kostense, et al. 2004. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not: the Hoorn Study. Atherosclerosis 174: 49-56.
16. Vladimirova-Kitova, L., T. Deneva, E. Angelova, et al. 2008. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia. Clin. Physiol. Funct. Imaging 28: 417-425.
17. Inaba, Y., J.A. Chen & S.R. Bergmann. 2010. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int. J. Cardiovasc. Imaging 26: 631-640.
18. Hooper, L., P.A. Kroon, E.B. Rimm, et al. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88: 38-50.
19. Ras, R.T., P.L. Zock & R. Draijer. 2011. Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 6: e16974.
20. Li, S.H, X. Liu, Y.Y. Bai, et al. 2010. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am. J. Clin. Nutr. 91: 480-486.
21. Cohen, R.A., A. Poppas, D.E. Forman, et al. 2009. Vascular and cognitive functions associated with cardiovascular disease in the elderly. J. Clin. Exp. Neuropsychol. 31: 96-110.
22. Forman, D.E., R.A. Cohen, K.F. Hoth, et al. 2008. Vascular health and cognitive function in older adults with cardiovascular disease. Artery Res. 2: 35-43.
23. Feringa, H.H.H., D.A. Laskey, J.E. Dickson & C.I. Coleman. 2011. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J. Am. Diet Assoc. 111: 1173-1181.
24. Mellen, P.B., K.R. Daniel, K.B. Brosnihan, et al. 2010. Effect of muscadine grape seed supplementation on vascular function in subjects with or at risk for cardiovascular disease: a randomized crossover trial. J. Am. Coll. Nutr. 29: 469-475.
25. Lekakis, J., L.S. Rallidis, I. Andreadou, et al. 2005. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil. 12: 596-600.
26. Clifton, P.M. 2004. Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. J. Biomed. Biotechnol. 5: 272-278.
27. Fujitaka, K., H. Otani, F. Jo, et al. 2011. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr. Res. 31: 842-847.
28. Magyar, K., R. Halmosi, A. Palfi, et al. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin. Hemorheol. Microcirc. 50: 179-187.
29. Wong, R.H.X., P.R.C. Howe, J.D. Buckley, et al. 2011. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis. 21: 851-856.
30. Widlansky, M.E., S.J. Duffy, N.M. Hamburg, et al. 2005. Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic. Biol. Med. 38: 499-506.
31. Widlansky, M.E., N.M. Hamburg, E. Anter, et al. 2007. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Nutr. 26: 95-102.
32. EFSA. 2012. Scientific opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 10: 2809.
33. Wong, R.H.X., N.M. Berry, A.M. Coates, et al. 2012. Sustained improvement of vasodilator function by resveratrol in obese adults. J. Hypertens. 30: e70.
34. Chachay, V.S., C.M. Kirkpatrick, I.J. Hickman, et al. 2011. Resveratrol-pills to replace a healthy diet? Br. J. Clin. Pharmacol. 72: 27-38.
35. Sinn, N. & P.R.C. Howe. 2008. Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function. Biosci. Hypotheses 1: 103-108.
36. Francis, S.T., K. Head, P.G. Morris & I.A. Macdonald. 2006. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J. Cardiovasc. Pharmacol. 47: S215-S220.
37. Wong, R.H., P.R. Howe, A.M. Coates, et al. 2013. Chronic consumption of a wild green oat extract (Neuravena) improves brachial flow-mediated dilatation and cerebrovascular responsiveness in older adults. J. Hypertens. 31: 192-200.
38. Kennedy, D.O., E.L. Wightman, J.L. Reay, et al. 2010. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 91: 1590-1597.
39. Desideri, G., C. Kwik-Uribe, D. Grassi, et al. 2012. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension 60: 794-801.
40. Badcock, N.A., G. Holt, A. Holden & D.V.M. Bishop. 2012. dopOSCCI: a functional transcranial Doppler ultrasonography summary suite for the assessment of cerebral lateralization of cognitive function. J. Neurosci. Meth. 204: 383-388.